Medikaz: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Medikaz
Largest movements
- Cash -€9,123
down €9,123 (-60.1%), from €15,172 to €6,049
mainly Debts after one year (-€12,904) and Contributions, distributions and other (-€7,613)
- Tangible fixed assets -€7,121
down €7,121 (-2.9%), from €245,795 to €238,674
- Debts after one year -€12,904
down €12,904 (-5.8%), from €220,603 to €207,699
- Reserves -€2,920
down €2,920 (-38.4%), from €7,613 to €4,693
- Gross operating margin +€2,055
up €2,055 (+12.2%), from €16,854 to €18,909
- Taxes +€1,550
up €1,550 (+517%), from €300 to €1,850
- Other operating charges +€1,162
up €1,162 (+985%), from €118 to €1,280
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €261,567 | €244,723 | -€16,844 | -6.4% |
| Fixed assets | 21/28 | €245,795 | €238,674 | -€7,121 | -2.9% |
| Tangible fixed assets | 22/27 | €245,795 | €238,674 | -€7,121 | -2.9% |
| Land and buildings | 22 | €245,795 | €238,674 | -€7,121 | -2.9% |
| Current assets | 29/58 | €15,772 | €6,049 | -€9,723 | -61.6% |
| Amounts receivable within one year | 40/41 | €600 | - | -€600 | |
| Trade receivables | 40 | €600 | - | -€600 | |
| Cash at bank and in hand | 54/58 | €15,172 | €6,049 | -€9,123 | -60.1% |
| Total equity and liabilities | 10/49 | €261,567 | €244,723 | -€16,844 | -6.4% |
| Equity | 10/15 | €17,633 | €14,713 | -€2,920 | -16.6% |
| Contributions | 10/11 | €10,020 | €10,020 | = | 0.0% |
| Reserves | 13 | €7,613 | €4,693 | -€2,920 | -38.4% |
| Distributable reserves | 133 | €7,613 | €4,693 | -€2,920 | -38.4% |
| Amounts payable | 17/49 | €243,934 | €230,010 | -€13,924 | -5.7% |
| Amounts payable after more than one year | 17 | €220,603 | €207,699 | -€12,904 | -5.8% |
| Financial debts | 170/4 | €220,603 | €207,699 | -€12,904 | -5.8% |
| Amounts payable within one year | 42/48 | €23,331 | €22,311 | -€1,020 | -4.4% |
| Current portion of amounts payable after more than one year | 42 | €12,903 | €12,904 | +€1 | 0.0% |
| Trade debts | 44 | €117 | - | -€117 | |
| Suppliers | 440/4 | €117 | - | -€117 | |
| Taxes, remuneration and social security | 45 | €300 | €1,783 | +€1,483 | +495% |
| Taxes | 450/3 | €300 | €1,783 | +€1,483 | +495% |
| Other amounts payable | 47/48 | €10,011 | €7,624 | -€2,387 | -23.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,121 | €7,121 | = | 0.0% |
| Other operating charges | 640/8 | €118 | €1,280 | +€1,162 | +985% |
| Gross operating margin | 9900 | €16,854 | €18,909 | +€2,055 | +12.2% |
| Operating profit (loss) | 9901 | €9,615 | €10,508 | +€893 | +9.3% |
| Financial income | 75/76B | - | €3 | +€3 | |
| Recurring financial income | 75 | - | €3 | +€3 | |
| Financial charges | 65/66B | €4,122 | €3,967 | -€155 | -3.8% |
| Recurring financial charges | 65 | €4,122 | €3,967 | -€155 | -3.8% |
| Profit (loss) for the period before taxes | 9903 | €5,492 | €6,543 | +€1,051 | +19.1% |
| Income taxes | 67/77 | €300 | €1,850 | +€1,550 | +517% |
| Profit (loss) for the period | 9904 | €5,193 | €4,693 | -€500 | -9.6% |
| Profit (loss) for the period to be appropriated | 9905 | €5,193 | €4,693 | -€500 | -9.6% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.